Multiple sclerosis - Difficult answers to easy questions;Stwardnienie rozsiane - Trudne odpowiedzi na proste pytania

Neurologia i Neurochirurgia Polska

Volumn 40, Issue 5, 2006, Pages 441-445

  Bartosik Psujek, Halina ^a   Stelmasiak, Zbigniew ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Delivery; Mutiple sclerosis; Pregnancy; Prognosis; Stress; Temperature; Vaccination

Indexed keywords

AUTOIMMUNE DISEASE; DELIVERY; DIETARY INTAKE; DISEASE COURSE; HUMAN; INFECTION; LIFESTYLE; LONG TERM CARE; MULTIPLE SCLEROSIS; PHYSICAL DISABILITY; PREDICTION; PREGNANCY; PROGNOSIS; PUERPERIUM; RELAPSE; REVIEW; RISK FACTOR; STRESS; TEMPERATURE; VACCINATION;

ACTIVITIES OF DAILY LIVING; DISABILITY EVALUATION; DISEASE PROGRESSION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NEUROGENIC INFLAMMATION; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 33751034044     PISSN: 00283843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Scott T.F., Schramke C.J., Novero J. i wsp. Short-term prognosis in early relapsing-remitting multiple sclerosis. Neurology 2000; 55: 689-693.
2. Myhr K.M., Riise T, Vedeler C. i wsp. Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension. Mult Scler 2001; 7: 59-65.
3. Confavreux C., Vukusic S., Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003; 126: 770-782.
4. Miller D., Barkhof F, Montalban X. i wsp. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol 2005; 4: 281-288.
5. Amato M.P., Ponziani G. A prospective study on the prognosis of multiple sclerosis. Neurol Sci 2000; 21 (supl. 2): S831-S838.
6. Simmons R.D., Ponsonby A.L., van der Mei I.A. i wsp. What affects your MS? Responses to an anonymous, Internet-based epidemiological survey. Mult Scler 2004; 10: 202-211.
7. van der Mei I.A.F., Ponsonby A.-L., Blizzard L. i wsp. Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation. Neuroepidemiology 2001; 20: 168-174.
8. van der Mei I.A.F., Ponsonby A.-L., Dwyer T. i wsp. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ 2003; 327: 316-321.
9. VanAmerongen B.M., Dijkstra C.D., Lips P. i wsp. Multiple sclerosis and vitamin D: an update. Eur J Clin Nutr 2004; 58: 1095-1109.
10. Brown R.F., Tennant C.C., Dunn S.M. i wsp. A review of stress-relapse interactions in multiple sclerosis: important features and stress-mediating and -moderating variables. Mult Scler 2005; 11: 477-484.
11. Buljevac D., Hop W.C., Reedeker W. i wsp. Self reported stressful life events and exacerbations in multiple sclerosis: prospective study. BMJ 2003; 327: 646.
12. Buljevac D., Flach H.Z., Hop W.C. i wsp. Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain 2002; 125: 952-960.
13. Schwarz S., Leweling H. Multiple sclerosis and nutrition. Mult Scler 2005; 11: 24-32.
14. Payne A. Nutrition and diet in the clinical management of multiple sclerosis. J Ham Natr Diet 2001; 14: 349-357.
15. Zipp F., Weil J.G., Einhaupl K.M. No increase in demyelinating diseases after hepatitis B vaccination. Nat Med 1999; 5: 964-965.
16. Ascherio A., Zhang S.M., Hernan M.A. i wsp. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 2001; 344: 327-332.
17. DeStefano, F, Verstraeten T, Jackson L.A. i wsp. Vaccine Safety Datalink Research Group, National Immunization Program, Centers for Disease Control and Prevention. Vaccinations and risk of central nervous system demyelinating diseases in adults. Arch Neurol 2003; 60: 504-509.
18. Confavreux C., Suissa S., Saddier P. i wsp. Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group. N Engl J Med 2001; 344: 319-326.
19. Rutschmann O.T., McCrory D.C., Matchar D.B. Immunization Panel of the Multiple Sclerosis Council for Clinical Practice Guidelines. Immunization and MS: a summary of published evidence and recommendations. Neurology 2002; 59: 1837-1843.
20. Confavreux C., Hutchinson M., Hours M.M. i wsp. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Eng J Med 1998; 339: 285-291.
21. Salemi G., Callari G., Gammino M. i wsp. The relapse rate of multiple sclerosis changes during pregnancy: a cohort study. Acta Neurol Scand 2004; 110: 23-26.
22. Vukusic S., Hutchinson M., Hours M. i wsp. The Pregnancy In Multiple Sclerosis Group. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 2004; 127: 1353-1360.
23. Achiron A., Kishner I., Dolev M. i wsp. Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis. J Neurol 2004; 251: 1133-1137.
24. Haas J., Hommes O., Bauer M. Management of multiple sclerosis after pregnancy: The GAMPP Study. ECTRIMS/ACTRIMS 2005.
25. Brown T.R., Kraft G.H. Exercise and rehabilitation for individuals with multiple sclerosis. Phys Med Rehabil Clin N Am 2005; 16: 513-555.
26. Rietberg M.B., Brooks D., Uitdehaag B.M. i wsp. Exercise therapy for multiple sclerosis. Cochrane Database Syst Rev 2005, 25: CD003980.
27. Freeman J.A., Hobart J.C., Playford E.D. i wsp. Evaluating neurorehabilitation: lessons from routine data collection. J Neurol Neurosurg Psychiatry 2005; 76: 723-728.
28. Kesselring J., Beer S. Symptomatic therapy and neurorehabilitation in multiple sclerosis. Lancet Neurol 2005; 4: 643-652.
29. Wiles C.M., Newcombe R.G., Fuller K.J. i wsp. Controlled randomised crossover trial of the effects of physiotherapy on mobility in chronic multiple sclerosis. J Neurol Neurosurg Psychiatry 2001; 70: 174-179.